Russell Investments Group
IBB icon

Russell Investments Group’s iShares Biotechnology ETF IBB Stock Holding History

Russell Investments Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82K Sell
431
-68
-14% -$11.7K ﹤0.01% 3507
2026
Q1 		$84.3K Sell
499
-241
-33% -$41.2K ﹤0.01% 3143
2025
Q4 		$125K Buy
740
+43
+6% +$6.98K ﹤0.01% 2983
2025
Q3 		$101K Buy
697
+544
+356% +$74.3K ﹤0.01% 3027
2025
Q2 		$19.4K Buy
153
+105
+219% +$12.9K ﹤0.01% 3200
2025
Q1 		$6.14K Sell
48
-53
-52% -$7.19K ﹤0.01% 3315
2024
Q4 		$13.4K Buy
101
+47
+87% +$6.61K ﹤0.01% 3085
2024
Q3 		$7.86K Buy
+54
New +$7.81K ﹤0.01% 3138

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

Russell Investments Group's IBB Position: Q2 2026 in Review

Russell Investments Group reduced its iShares Biotechnology ETF (IBB) stake by 14% in Q2 2026, selling an estimated $11.7K and leaving 431 shares worth $82K. The position accounts for ﹤0.01% of the portfolio, ranked #3507.

Russell Investments Group first reported a position in IBB in Q3 2024 and has held it in 8 quarters since. The position peaked at $125K in Q4 2025. 699 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Russell Investments Group held 431 shares of iShares Biotechnology ETF worth $82K as of Q2 2026.
  • Russell Investments Group sold 68 iShares Biotechnology ETF shares in Q2 2026, an estimated $11.7K.
  • iShares Biotechnology ETF made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3507 holding.
  • Russell Investments Group first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 8 quarters since.
  • Russell Investments Group's iShares Biotechnology ETF position peaked at $125K in Q4 2025.
  • 699 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.